Recipient of the 2024 Louis W. Sullivan, MD, Award: Deidra C. Crews, MD, ScM

Deidra C. Crews, MD, ScM
Dr. Crews
 

The American Society for Clinical Investigation is pleased to recognize Deidra C. Crews, MD, ScM, as the recipient of the 2024 Louis W. Sullivan, MD, Award, for her scientific contributions to addressing disparities in the care and outcomes of kidney disease and hypertension. Dr. Crews, who will be recognized at the 2024 AAP/ASCI/APSA Joint Meeting, receives an honorarium of $10,000, and delivers a scientific talk at the 2025 meeting.

Dr. Crews is a nephrologist and epidemiologist and among the most influential researchers worldwide advancing kidney health equity. Her seminal studies (among >250 publications) show: low socioeconomic status (SES) differentially impacts CKD risk and associated mortality among Black versus White Americans; limited access to healthy foods and housing insecurity are potent risk factors for poor CKD outcomes; diet quality impacts CKD risk especially for minoritized persons with low SES; perceived discrimination is associated with progressive loss of kidney function; and functional status of older and low SES adults with kidney failure is improved through a novel home-based intervention. She led studies to define the optimal level of kidney function at which kidney replacement therapy should be initiated, contributing to reversal of the US practice of initiating dialysis in patients still with significant residual kidney function. She led a dietary intervention trial for Black adults with CKD, hypertension and low SES whose results could solidify dietary modification as recommended therapy for this population. She is deputy director of a model health equity research center and co-PI of two NIH center awards focused on advancing equity in kidney and cardio-metabolic diseases.

As a Black American descendant of enslaved people with a strong family history of kidney disease, I have devoted my career to improving the kidney health of people from socially marginalized groups and to advancing inclusive excellence in the biomedical workforce.

— Dr. Crews

Dr. Susan E. Quaggin nominated Dr. Crews for the Award, stating, “Her work has informed clinical guidelines and has catalyzed the study of social drivers of disparities in chronic kidney disease.” Dr. Quaggin emphasized the influence of Dr. Crews’ work and the accolades she has received for exceptional research, leadership, and mentorship, such as the Johns Hopkins University President’s Frontier Award, election to the National Academy of Medicine (2023), and the Distinguished Leader Award from the American Society of Nephrology, an organization for which Dr. Crews is the first Black president.

Dr. Crews earned her BA from the University of Virginia and her MD from Saint Louis University School of Medicine. She completed a nephrology fellowship and a master’s degree in clinical epidemiology at Johns Hopkins, where she was selected as a Harold Amos Medical Faculty Development Program Scholar, sponsored by the Robert Wood Johnson Foundation. Dr. Crews is now Professor of Medicine in the Division of Nephrology at Johns Hopkins University School of Medicine. She holds appointments in the School of Nursing; the Department of Epidemiology; the Welch Center for Prevention, Epidemiology and Clinical Research; the Center on Aging and Health; and the Center for Health Equity, where she is Deputy Director. She was elected to the American Society for Clinical Investigation in 2020.

Recipient of the 2024 Marian W. Ropes, MD, Award: Renee Yuen-Jan Hsia, MD, MSc

Renee Yuen-Jan Hsia, MD, MSc
Dr. Hsia

The American Society for Clinical Investigation is pleased to recognize Renee Yuen-Jan Hsia, MD, MSc, as the recipient of the 2024 ASCI/Marian W. Ropes, MD, Award, for her scientific contributions to understanding the relationship between access to emergency care and disparities in the health care system. Dr. Hsia, who will be recognized at the 2024 AAP/ASCI/APSA Joint Meeting, receives an honorarium of $10,000, and delivers a scientific talk at the 2025 meeting.

Dr. Hsia’s work has elucidated how market-driven imbalances in the supply and demand of emergency care produce preventable mortality and exacerbate underlying inequities. She investigates issues relating to population access to emergency departments and trauma centers; the distribution of emergency care across income areas; factors associated with closure of emergency services; how these closures affect patient outcomes, specifically focusing on patients with acute myocardial infarction, stroke, asthma/COPD, sepsis, and trauma; and the variation of costs and charges in the health care system.

My energy, and my passion, is rooted in daily encounters with patients who cannot access the benefits of our system as easily as others, and my work is based on a conviction that systems and structures must be considered carefully with attention to both efficiency and equity.
— Dr. Hsia

In nominating Dr. Hsia, Dr. Harlan M. Krumholz wrote, “In the ten years that I have known her, I have been privileged to see how her humanity is what ultimately drives her perseverance and capacity for critical analysis, as well as her unwavering commitment to studying issues that fundamentally contribute to the structural inequity of our health care system.” Dr. Krumholz noted Dr. Hsia’s highly cited academic research, which has also gained extensive attention in popular media.

Dr. Hsia received her BA from Princeton University and MSc from the London School of Economics and the London School of Hygiene and Tropical Medicine. She earned her MD at Harvard Medical School and completed an internship and residency at Stanford University. Dr. Hsia is now Professor of Emergency Medicine and Health Policy; Vice Chair of Health Services Research in the Department of Emergency Medicine, where she was hired as the first woman researcher on a research track; and a member of the Philip R. Lee Institute for Health Policy Studies at the University of California, San Francisco. She is the founder and director of the UCSF Policy Lab of Acute Care and Emergencies (PLACE). As a clinician, she attends at the San Francisco General Hospital and Trauma Center, a county hospital where most indigent patients, along with documented and undocumented immigrants, receive care and where she regularly uses her skills in Cantonese, Mandarin, and Spanish. Dr. Hsia was elected to the American Society for Clinical Investigation in 2019.

 

The 2024 Harrington Prize for Innovation in Medicine: Arlene H. Sharpe, MD, PhD

The eleventh annual Harrington Prize for Innovation in Medicine has been awarded to Arlene H. Sharpe, MD, PhD, Kolokotrones University Professor and Chair of the Department of Immunology at Harvard Medical School. The award recognizes her breakthrough discoveries in immune regulation, which have established foundational principles in immunology and led to new cancer therapies that act by boosting the immune response to cancer.

The Harrington Prize for Innovation in Medicine, established in 2014 by the Harrington Discovery Institute at University Hospitals and the American Society for Clinical Investigation (ASCI), honors physician-scientists who have moved science forward with achievements notable for innovation, creativity and potential for clinical application.

Dr. Sharpe’s research in immunology has led to significant advances in medical treatments. Her work helped identify key pathways that restrain the activity of T lymphocytes (immune cells) to fight cancer. Her work defined the PD-1 pathway and its immunoinhibitory functions as well as the inhibitory functions of CTLA-4 to restrain the activity of the immune system.

Dr. Sharpe’s research thus laid the foundation for the development of ‘immune checkpoint inhibitors’, drugs that target PD-1 and related pathways. These therapies, including pembrolizumab and nivolumab, have been approved by the FDA for treating numerous types of cancer. They work by preventing inhibition of T cell function, thereby unleashing the body’s immune system to fight cancer cells more effectively. This approach has become a cornerstone in cancer treatment strategies.

“Dr. Sharpe’s body of work has shaped our understanding of the role of the T cell in regulating the immune response. Her innovative scientific discoveries are among the best examples of bench-to-bedside work in the past three decades,” said Benjamin D. Humphreys, MD, PhD, Joseph Friedman Professor of Renal Diseases in Medicine and Chief, Division of Nephrology, Washington University in St. Louis and 2023-2024 President of the ASCI.

“Immune checkpoint inhibitors are drugs that allow for dramatic remission, and even cures, of cancers that had previously been considered untreatable. Dr. Sharpe’s foundational insights have thus been harnessed to transform cancer therapy. Her work provides a beautiful example of physician impact through creative science,” said Jonathan S. Stamler, MD, President, Harrington Discovery Institute, Robert S. and Sylvia K. Reitman Family Foundation Distinguished Professor of Cardiovascular Innovation and Professor of Medicine and of Biochemistry at University Hospitals and Case Western Reserve University.

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board reviewed nominations from leading academic medical centers globally before selecting the 2024 Harrington Prize recipient.

In addition to sharing the Prize’s $20,000 honorarium, Dr. Sharpe will deliver the Harrington Prize Lecture at the 2024 AAP/ASCI/APSA Joint Meeting on April 5, will be a featured speaker at the 2024 Harrington Scientific Symposium May 22-23, and will publish an essay in the Journal of Clinical Investigation.

The Harrington Prize has recognized outstanding and diverse innovations in medicine:

  • 2014: Harry Dietz, MD, Johns Hopkins University, for his contributions to the understanding of the biology and treatment of Marfan syndrome, a disorder leading to deadly aneurysms in children and adults.
  • 2015: Douglas R. Lowy, MD, The National Cancer Institute, in recognition of his discoveries that led to the development of the Human Papillomavirus vaccine to prevent cervical cancer.
  • 2016: Jeffrey M. Friedman, MD, PhD, The Rockefeller University, for his discovery of leptin, which controls feeding behavior and is used to treat related clinical disorders.
  •  2017: Jointly awarded to Daniel J. Drucker, MD, Mount Sinai Hospital, Canada, Joel F. Habener, MD, Massachusetts General Hospital, and Jens J. Holst, MD, DMSc, University of Copenhagen, Denmark, for their discovery of incretin hormones and for the translation of these findings into transformative therapies for major metabolic diseases such as diabetes.
  • 2018: Helen H. Hobbs, MD, UT Southwestern Medical Center, for the discovery of the link between a gene mutation (PCSK9) and lower levels of LDL, which has improved the treatment of high cholesterol.
  • 2019: Carl H. June, MD, University of Pennsylvania, for advancing the clinical application of CAR T therapy for cancer treatment, and for his sustained contributions to the field of cellular immunology.
  • 2020: Stuart H. Orkin, MD, Harvard University, for breakthrough discoveries on red blood cells that offer new treatments for patients with sickle cell disease and beta-thalassemia, which are among the most common genetic disorders.
  •  2021: Warren J. Leonard, MD, and John J. O’Shea, MD, NIH, for their respective contributions to the field of immunology, from fundamental discovery to therapeutic impact.
  •  2022: James E. Crowe Jr., MD, and Michel C. Nussenzweig, MD, PhD, for their groundbreaking work, which has elucidated fundamental principles of the human immune response and enabled the use of human antibodies to treat COVID-19.
  •  2023: Jean Bennett, MD, PhD, and Albert M. Maguire, MD, for their groundbreaking translational research to restore sight in inherited genetic diseases.

New Active and International members elected for 2024

The ASCI is pleased to announce the election of 100 Active and International members for 2024.

These new members come from 50 different institutions and represent excellence across the breadth of academic medicine. They will be officially inducted into the Society at the ASCI Dinner and New Member Induction Ceremony, April 5, 2024, as part of the AAP/ASCI/APSA Joint Meeting, April 5–7, at the Swissotel Chicago.

The 2024 Active and International members:

MemberInstitution
Allison Lorna Agwu, MD, ScMJohns Hopkins University School of Medicine
Cristina Maria Alvira, MDStanford University School of Medicine
Liana Apostolova, MD, MScIndiana University School of Medicine
Pankaj Arora, MD, FAHA, FASEUniversity of Alabama at Birmingham School of Medicine
Ruanne Vanessa Barnabas, MBChB, MSc, DPhilHarvard Medical School, Massachusetts General Hospital
Miles Berger, MD, PhDDuke University School of Medicine
Arthur Beyder, MD, PhDMayo Clinic
Mitesh Jivraj Borad, MDMayo Clinic
Angela R. Bradbury, MDUniversity of Pennsylvania Perelman School of Medicine
Jonathan D. Brown, MDVanderbilt University School of Medicine
James Edward Cassat, MD, PhDVanderbilt University School of Medicine
Lilia Cervantes, MD, MSCSUniversity of Colorado School of Medicine
Lin Yee Chen, MBBS, MSUniversity of Minnesota Medical School
Matthew Aaron Ciorba, MDWashington University School of Medicine in St. Louis
Scott M. Damrauer, MDUniversity of Pennsylvania Perelman School of Medicine
John P. Dekker, MD, PhDNational Institutes of Health
Evan Samuel Dellon, MD, MPHUniversity of North Carolina School of Medicine
Robert Pickett Dickson, MDUniversity of Michigan Medical School
Nico Urs Felix Dosenbach, MD, PhDWashington University School of Medicine in St. Louis
Vikas Dudeja, MBBS, FACSUniversity of Alabama at Birmingham School of Medicine
Jeffrey D. Dvorin, MD, PhDHarvard Medical School, Boston Children's Hospital
E. Jennifer Edelman, MD, MHSYale School of Medicine
Susan D. Emmett, MD, MPHUniversity of Arkansas College of Medicine
Michelle Mae Estrella, MD, MHSUniversity of California, San Francisco, School of Medicine
Carmella Evans-Molina, MD, PhDIndiana University School of Medicine
Amani A. Fawzi, MD, MSc, DScNorthwestern University Feinberg School of Medicine
Courtney Dayle Fitzhugh, MDNIH, National Heart, Lung, and Blood Institute (NHLBI)
Elizabeth E. Foglia, MD, MSCEUniversity of Pennsylvania Perelman School of Medicine
Karunesh Ganguly, MD, PhDUniversity of California, San Francisco, School of Medicine
Marcus DaSilva Goncalves, MD, PhDWeill Cornell Medicine
Monika Kumari Goyal, MD, MSCEGeorge Washington University School of Medicine & Health Sciences
Peter Christopher Grayson, MD, MScNIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Kira Gritsman, MD, PhDAlbert Einstein College of Medicine
David Sullivan Hains, MD, MBAIndiana University School of Medicine
Brent A. Hanks, MD, PhDDuke University Medical Center
Tamia A. Harris-Tryon, MD, PhDUniversity of Texas Southwestern Medical Center
Jeffrey A. Haspel, MD, PhDWashington University School of Medicine in St. Louis
Timothy Jensen Henrich, MD, MMScUniversity of California, San Francisco, School of Medicine
Christian S. Hinrichs, MDRutgers, Robert Wood Johnson Medical School
Jennifer En-Sian Ho, MDHarvard Medical School, Beth Israel Deaconess Medical Center
Craig Michael Horbinski, MD, PhDNorthwestern University Feinberg School of Medicine
Christopher Simon Hourigan, DM, DPhil, FRCPNational Institutes of Health
Sohail Z. Husain, MDStanford University School of Medicine
Samar H. Ibrahim, MBChBMayo Clinic
Rodney Elwood Infante, MD, PhDUniversity of Texas Southwestern Medical Center
Daniel J. Jackson, MDUniversity of Wisconsin School of Medicine and Public Health
Joanne Michelle Kahlenberg, MD, PhDUniversity of Michigan Medical School
Kiran Kaur Khush, MD, MAS, FACCStanford University School of Medicine
Betty Y.S. Kim, MD, PhD, FRCSC, FAANSUniversity of Texas MD Anderson Cancer Center
Dae Hyun Kim, MD, MPH, ScDHarvard Medical School, Beth Israel Deaconess Medical Center
Justin Paul Kline, MDUniversity of Chicago Medical Center
Frederick Kofi Korley, MD, PhDUniversity of Michigan Medical School
Carl Koschmann, MDUniversity of Michigan Medical School
Elaine Ku, MD, MASUniversity of California, San Francisco, School of Medicine
Li Lan, MD, PhDDuke University School of Medicine
Charles Regis Langelier, MD, PhDUniversity of California, San Francisco, School of Medicine
John Kyung Lee, MD, PhDUniversity of California, Los Angeles, David Geffen School of Medicine
Jung-Min Lee, MDNIH, National Cancer Institute (NCI)
JoAnna Kristine Leyenaar, MD, PhD, MPHDartmouth Geisel School of Medicine
Kian-Huat Lim, MD, PhDWashington University School of Medicine in St. Louis
Robert Coleman Lindsley, MD, PhDHarvard Medical School, Dana-Farber Cancer Institute
Elizabeth Dawn Lowenthal, MD, MSCEChildren's Hospital of Philadelphia
Jeffrey A. Magee, MD, PhDWashington University School of Medicine in St. Louis
Steven E. Mansoor, MD, PhDOregon Health & Science University
Rozalina G. McCoy, MD, MSUniversity of Maryland School of Medicine
Reena Mehra, MD, MSCleveland Clinic
Madhav Chandrasekhar Menon, MD, MBBSYale School of Medicine
Jonathan J. Miner, MD, PhDUniversity of Pennsylvania Perelman School of Medicine
Kent William Mouw, MD, PhDHarvard Medical School, Dana-Farber Cancer Institute
Nikhil Vilas Munshi, MD, PhDUniversity of Texas Southwestern Medical Center
Samir Sunil Parekh, MDIcahn School of Medicine at Mount Sinai
Jonathan B. Parr, MD, MPHUniversity of North Carolina School of Medicine
William Hughes Peranteau, MDChildren's Hospital of Philadelphia
Craig Evan Pollack, MD, MHSJohns Hopkins Bloomberg School of Public Health
Read Pukkila-Worley, MDUniversity of Massachusetts Medical School
Babak Razani, MD, PhDUniversity of Pittsburgh School of Medicine
Armin Raznahan, MD, PhD, MRCPCH, MRCPsychNIH, National Institute of Mental Health (NIMH)
Nadine Rouphael, MD, MSc, FSSCI, FIDSAEmory University School of Medicine
Takeshi Saito, MD, PhD, FAGAUniversity of Southern California Keck School of Medicine
Matthew G. Sampson, MD, MSCEHarvard Medical School, Boston Children's Hospital
Tiffany C. Scharschmidt, MDUniversity of California, San Francisco, School of Medicine
John Alexis Schneider, MD, MPHUniversity of Chicago Medical Center
Matthew Semler, MD, MScVanderbilt University School of Medicine
Amil Madhukar Shah, MD, MPHUniversity of Texas Southwestern Medical Center
N. Sarita Shah, MD MPHEmory University School of Medicine
Sanjiv J. Shah, MDNorthwestern University Feinberg School of Medicine
Benjamin David Singer, MDNorthwestern University Feinberg School of Medicine
Douglas R. Stewart, MDNIH, National Cancer Institute (NCI)
Steve Myer Taylor, MD, MPHDuke University School of Medicine
Zian Huan Tseng, MD, MASUniversity of California, San Francisco, School of Medicine
Miguel Valderrabano, MD, PhDHouston Methodist, Texas Medical Center
Sriram Venneti, MD, PhDUniversity of Michigan Medical School
Sushrut S. Waikar, MD, MPHBoston University School of Medicine
Yinghong (Mimi) Wang, MD, PhD, MScUniversity of Texas MD Anderson Cancer Center
Arun Paul Wiita, MD, PhDUniversity of California, San Francisco, School of Medicine
F. Perry Wilson, MD MSCEYale School of Medicine
Alexi A. Wright, MD, MPHHarvard Medical School, Dana-Farber Cancer Institute
Rona D. Yaeger, MDMemorial Sloan Kettering Cancer Center
Robert W. Yeh, MD, MSc, MBAHarvard Medical School, Beth Israel Deaconess Medical Center
Jindan Yu, MD, PhDEmory University School of Medicine

For the 2024 Active and International membership nomination cycle, the Council received and considered 302 nominations, from which it recommended 100 nominees (the maximum) for election. The Active, International, and Senior segments of the membership voted on the recommendation from November 29 through December 6, with 43% of eligible voters submitting their ballots. The vote was overwhelmingly in favor of approving the recommendation. Dr. Elizabeth Speliotes, in her role as the ASCI’s 2023–2025 Secretary-Treasurer, oversaw auditing of the ballot. Drs. Benjamin Humphreys and Priscilla Hsue served as auditors.

Nominations for ASCI Council, 2024

The Society seeks nominations for the following ASCI Council vacancies arising in 2023 (all terms begin and end in the spring):

  • Vice President (4-year term, 2024-2028)
  • Secretary-Treasurer Elect (3-year term, 2022-2025; first year is Councilor position, transitioning to Secretary-Treasurer for years 2 and 3)
  • Councilor (one position, 3-year term, 2024-2027)

Those eligible for nomination must be in the Active category and:

  • for Vice President, do not turn 56 until 2029 or later
  • for other positions, do not turn 56 until 2028 or later

The Society strongly encourages members to consider diversity in identifying those suitable for nomination. Self-nominations are not permitted. Nominations may be submitted by any member in good standing (with dues up to date if applicable) and must be submitted by January 16, 2024, at 11:59 PM EST.

All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, with the spring meeting occurring as part of the annual meeting) and videoconference calls (typically every other month). All Council members participate in the review of membership and Stanley J. Korsmeyer Award nominations and subsequent discussion at the fall meeting.

The Vice President transitions to President-Elect in year 2, President in year 3, and Immediate Past President in year 4. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the annual meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program and presents the traditional Presidential Address at the meeting.

The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

Nominators:

  • may be any ASCI member
  • must provide a statement (250-word limit) regarding the nominee

Nominees:

  • must specify the position of interest (Vice President, Secretary-Treasurer Elect, Councilor);
  • must provide the following:
    • a 250-word candidate statement, written in first person, for consideration by the Council and for use as the ballot statement if the nominee is selected as a candidate. The nominee must provide the statement by email to staff@the-asci.org by the deadline noted above. (Nominees may refer to candidate statements for the 2022 nomination cycle for guidance in drafting their own statements.)
    • an NIH-style biosketch;
  • and must complete the ASCI’s demographic survey.

To start a nomination:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for “Council nominations”:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

Nominations open for 2024 Honorary membership

The ASCI is pleased to call for nominations for 2024 Honorary membership. Nominees for this recognition must fit the criteria as given in the ASCI bylaws:

Any distinguished person who has contributed significantly to the Society’s objectives, who has not been previously and unsuccessfully nominated for Active or International membership, and who enjoys an unimpeachable moral standing is eligible for nomination in this category.

For the nominee who meets these criteria, there is no restriction on age or degree held.

The deadline for receipt of nominations is January 16, 2024, at 11:59 pm Eastern (extended from December 8 , 2023). Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations and submits its recommendations to Active and Senior members for approval.

Nominators:

  • must be an ASCI member in good standing, including members of the Council, and
  • must provide a statement (250-word limit) regarding the nominee.

Nominees:

  • must provide a full curriculum vitae and
  • must complete the ASCI’s demographic survey.

To start a nomination:

The nominator must initiate the process:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for “Honorary membership”:
    • Select “I’m the nominator” option
    • Search for your nominee:
      • If found, click on “Create nomination”.
      • If no result is found, enter the requested information (first name, last name, and email address), save, and then click on “Create nomination”.
    • At the top of the nomination form, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).

 

Call for applications to ASCI’s Postbac Program

The ASCI is pleased to call for applications for the Society’s new Postbac Program.

This program provides an intensive, two-year mentored laboratory research experience for students that will expose them to the physician-scientist career path, strengthen their applications to MD or MD-PhD programs, and enhance their career development.

From the applicants, two finalists will be selected and each matched with a host lab where the Principal Investigator is an ASCI member with an outstanding mentoring record and resources to ensure in-depth research training. The two-year period will be mid-2024 through mid-2026.

Applicants are college graduates who are either in their last year of undergraduate study or received their bachelor’s degree within TWO years at the time of submission. Applicants should intend to apply to medical school during their second year of the Postbac Program.

Applications consist of:

  • a 750-word essay that describes your research experience, current interests and career goals, and anything else you would like us to know about you;
  • an undergraduate transcript (PDF);
  • a curriculum vitae (PDF);
  • headshot photograph (JPG etc.) (this file is not used in the review process);
  • two letters of recommendation (see more below); and
  • a completed ASCI demographics survey.

The application deadline is March 4, 2024, at 11:59 pm Eastern (extended from February 16). See the Postbac Program FAQ section for additional key dates.

Interested in applying?

Email staff@the-asci.org to request that an application be set up. You’ll receive an email providing information to access your application.

  • You can return to and edit the application until you’ve submitted it.
  • If you submit the application before the deadline and wish to edit it, email us and we’ll reopen the application.

Letters of recommendation

In your application, you’ll see a “Letters of recommendation” section where you can look up your supporters and add them if not found in our database. Supporters do not need to be affiliated with the ASCI in any way.

You’re responsible for notifying supporters to provide their letters online. Supporters are asked to complete two sections:

  • a statement (500-word limit) detailing your strengths and suitability to this program; and
  • a brief statement regarding their relationship to you.

Note that you won’t be able to submit your application until you’ve notified your supporters. In this section, you’ll be able to see whether supporters’ forms are in progress or submitted. You’ll also receive an email notification when each supporter submits her/his form.

Call for volunteer: Chair of the new Philanthropy Committee

The ASCI seeks a volunteer to chair a newly established Philanthropy Committee.

The ideal volunteer ASCI member will help establish and nurture potential donors to the organization. The goal is to obtain major gifts that can be used to support the mission of the ASCI, including but not limited to supporting scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve the health of our communities.

As part of this mission, the ASCI provides two programs for early-career physician-scientists: the Young Physician-Scientist Awards (YPSAs), for those who are within 5 years of their first faculty appointment, and the Emerging-Generation (E-Gen) Awards, for those who are within 3 to 9 years of earning their MD, MD/PhD, or equivalent degrees. Both the YPSAs and E-Gen Awards are intended to connect early-career physician-scientists with the ASCI community through access to the annual AAP/ASCI/APSA Joint Meeting and virtual career development, mentorship, and networking opportunities.

This year, the ASCI has initiated a new program, the ASCI Postbac Program, that will support Underrepresented in Medicine and Science (UiMS) students in obtaining an intensive, mentored, laboratory research experience. The goal of this program is to expose students to the physician-scientist career pathway and strengthen their applications to MD or MD/PhD programs.

The Society envisions expanding these programs further to support the careers of physician-scientists, and the Philanthropy Committee Chair will play a critical role in these efforts.

The Chair will serve an initial 3-year term, joined by a Vice Chair (the current ASCI Secretary-Treasurer) and other ex-officio Council members. In addition, the Chair will be supported by other non-Council volunteer members (to be selected by the Chair with approval of the President) and ASCI staff. As part of donor cultivation, the Chair will be host of an annual donor-recognition dinner in Chicago on the evening prior to the start of the Joint Meeting.

The ASCI anticipates the effort for the Chair to be approximately 5 hours per month. The ASCI will provide reimbursement for travel and related expenses accrued for Committee work, including registration, hotel, and travel for the Joint Meeting.

Those interested should send a CV and a brief (~250-word) statement of interest, including relevant experience, by November 6 to staff@the-asci.org.

Nominations open for mid-career member awards, 2024

The ASCI is pleased to call for nominations for awards recognizing the scholarly achievements of mid-career members:

The Marian W. Ropes, MD, Award recognizes a middle-career woman physician-scientist. The annual award honors Dr. Ropes (1903–1994), a pioneer both as a researcher on the role of synovial fluid in joint diseases and as a woman in academic medicine. She was the first woman documented to have been elected to the ASCI. The recipient of this award receives a $10,000 honorarium, will be recognized at the ASCI’s 2024 annual meeting, and gives the Ropes Lecture at the 2025 meeting.

The Louis W. Sullivan, MD, Award recognizes a middle-career physician-scientist who is underrepresented in medicine and science. The award honors Dr. Sullivan (born 1933), a hematologist, health care advocate, and policy leader — having served as US Secretary of Health and Human Services — and who was the first Black physician-scientist elected to the ASCI. The recipient of this award receives a $10,000 honorarium, will be recognized at the ASCI’s 2024 annual meeting, and gives the Sullivan Lecture at the 2025 meeting.

ASCI members who were elected in 2019 or more recently may be nominated. Additionally:

  • For the Ropes Award, only female members are eligible for nomination.
  • For the Sullivan Award, only UiMS members are eligible for nomination.

The deadline for receipt of nominations is November 27, 2023, at 11:59 pm Eastern (extended from November 13). Nominations will be screened to ensure they are complete and fit the award criteria. The ASCI’s Diversity, Equity, and Inclusion Committee will review nominations and submit its recommendations to the ASCI Council for approval. We expect to notify nominees about the outcome by January 2024.

Nominators:

  • must be an ASCI member, except for current members of the ASCI Council and the ASCI Diversity, Equity, and Inclusion Committee, and
  • must provide a statement regarding the nominee (500-word limit).

Nominees:

  • must fit the criteria noted above and may not be current members of the ASCI Council and the ASCI Diversity, Equity, and Inclusion Committee;
  • may be nominated only for one ASCI award (for example, a nominee for the Ropes Award may not be nominated for the Sullivan Award, Korsmeyer Award, or Harrington Prize);
  • must provide the following:
    • a personal statement (750-word limit) on their scientific achievements, with attention to relevant personal and career history (including a statement of diversity), mentoring experience, and service to the community;
    • a full curriculum vitae; and
    • 3 most-significant publications, each with a 50-word annotation, followed by the member’s role in the publication, the journal name and publication year, and the Pubmed ID noted as “PMID:12345”;
  • and must complete the ASCI’s demographic survey.

To start a nomination:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for the award of interest:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information); note that this option will not be available for the Ropes Award for male members.
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who were elected starting 2019 will appear in the results. Note: for the Ropes Award, you will only be able to select a nominee who is a woman; for the Sullivan Award, you may select anyone who is within the election-year window, but nominations will be screened (based on the information the nominee provides in the demographics survey) to ensure that nominees fit the UiMS criterion.

Definition of UiMS

The ASCI defines underrepresented in medicine in science as follows: Underrepresented in medicine and science (UiMS) refers to populations that are underrepresented relative to their numbers in the general US population. This includes, but is not necessarily limited to, physician-scientists who identify in the following racial and/or ethnic groups: Black/African American, Hispanic or Latin American, Native American/American Indian or Alaska Native, and Native Hawaiian and other Pacific Islander; individuals with disabilities: physical or mental impairment that substantially limits one or more major life activities; and those with an educationally or financially disadvantaged background.

Nominations open for the 2024 ASCI / Stanley J. Korsmeyer Award

Nominations for the ASCI’s 2024 ASCI / Stanley J. Korsmeyer Award are now open.

This prestigious recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Award recognizes individuals for their advancement of knowledge in a specific field and for mentoring future generations of life science researchers. Information on all past honorees is available here.

Current Active and International ASCI members are eligible for nomination. Prior nominees who remain eligible may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

The deadline for receipt of nominations is October 25, 2023, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected toward the end of November 2023.

Nominators:

  • may be any ASCI member in good standing, including members of the Council, and
  • must provide a statement (250-word limit) regarding the nominee.

Nominees:

  • must currently be an Active or International member (age 55 or younger);
  • must provide a biosketch, full curriculum vitae, and a trainee table; and
  • must complete the ASCI’s demographic survey.

To start a nomination:

Nominations may be started by the nominator or the nominee:

  • Access your member account
  • Go to the “Activities / nominations” tab
  • Go to the section for “ASCI / Stanley J. Korsmeyer Award”

 

For the nominator:

  • Select “I’m the nominator” option
  • Search for your nominee
  • Click on “Create nomination”
  • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
  • Supply the required information (see above)
  • Submit this aspect of the nomination

For the nominee:

  • Select “I’m the nominee” option
  • Supply the required information (see above)
  • Submit this aspect of the nomination